Novocell uses embryonic stem cells to treat diabetes in mice

02/20/2008 | San Diego Union-Tribune · NYTimes.com

Scientists at San Diego-based Novocell were able to convert human embryonic stem cells into cells that secrete insulin and control diabetes in mice whose insulin-producing islet cells have been destroyed. The company plans to create a continuous pool of human embryonic stem cells ready for use in human therapies to treat people with diabetes.

View Full Article in:

San Diego Union-Tribune · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC